Association between maternal circulating IL-27 levels and preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Biomarker Discovery

Background:

• Preeclampsia is a serious pregnancy complication.
• Identifying reliable biomarkers for preeclampsia severity is crucial for effective management.

Purpose of the Study:

• To investigate the association between serum Interleukin-27 (IL-27) levels and the presence and severity of preeclampsia.
• To evaluate IL-27 as a potential biomarker for preeclampsia.

Main Methods:

• Serum IL-27 levels were measured using ELISA in 56 preeclamptic women, 21 healthy pregnant women, and 20 non-pregnant women.
• Statistical analyses were performed to compare IL-27 levels across the groups and correlate them with disease severity.

Main Results:

• Serum IL-27 levels were significantly higher in preeclamptic women compared to non-pregnant controls (p=0.0004).
• IL-27 levels were significantly elevated in severe preeclampsia compared to healthy pregnant women (p=0.0056), but not in mild preeclampsia (p=0.0964).
• Significantly higher IL-27 levels were observed in early and late-onset severe preeclampsia compared to gestation-matched healthy pregnancies.

Conclusions:

• Serum IL-27 levels are elevated in preeclampsia and correlate with disease severity.
• IL-27 shows potential as a useful biomarker for assessing preeclampsia severity.